PepGen slides on FDA partial hold on mid-stage trial for lead asset
Source: SeekingAlpha
2026-03-05 06:57:50 ET
More on PepGen
- Seeking Alpha’s Quant Rating on PepGen
- Historical earnings data for PepGen
- Financial information for PepGen
Read the full article on Seeking Alpha
For further details see:
PepGen slides on FDA partial hold on mid-stage trial for lead asset
PepGen Inc.
NASDAQ: PEPG
PEPG Trading
0.71% G/L:
$5.66 Last:
274,711 Volume:
$5.62 Open:
PEPG Latest News
March 04, 2026 04:05:00 pm
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
PEPG Stock Data
$378,802,714
40,177,150
1.23%
19
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
